Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2022

Upgrades

William Blair upgraded the previous rating for Foot Locker Inc (NYSE:FL) from Sell to Hold. For the second quarter, Foot Locker had an EPS of $1.10, compared to year-ago quarter EPS of $2.21. At the moment, the stock has a 52-week-high of $47.42 and a 52-week-low of $23.85. Foot Locker closed at $38.39 at the end of the last trading period.

Evercore ISI Group upgraded the previous rating for Schneider National Inc (NYSE:SNDR) from In-Line to Outperform. For the second quarter, Schneider National had an EPS of $0.72, compared to year-ago quarter EPS of $0.60. At the moment, the stock has a 52-week-high of $27.50 and a 52-week-low of $20.69. Schneider National closed at $24.80 at the end of the last trading period.

According to SVB Leerink, the prior rating for Elevance Health Inc (NYSE:ELV) was changed from Market Perform to Outperform. Elevance Health earned $8.04 in the second quarter, compared to $7.03 in the year-ago quarter. The stock has a 52-week-high of $506.79 and a 52-week-low of $451.37. At the end of the last trading period, Elevance Health closed at $503.54.

According to Credit Suisse, the prior rating for Vipshop Holdings Ltd (NYSE:VIPS) was changed from Neutral to Outperform. Vipshop Holdings earned $0.37 in the second quarter, compared to $0.32 in the year-ago quarter. The stock has a 52-week-high of $11.58 and a 52-week-low of $5.75. At the end of the last trading period, Vipshop Holdings closed at $9.99.

For Foot Locker Inc (NYSE:FL), Morgan Stanley upgraded the previous rating of Underweight to Equal-Weight. Foot Locker earned $1.10 in the second quarter, compared to $2.21 in the year-ago quarter. At the moment, the stock has a 52-week-high of $47.42 and a 52-week-low of $23.85. Foot Locker closed at $38.39 at the end of the last trading period.

Citigroup upgraded the previous rating for Bruker Corp (NASDAQ:BRKR) from Neutral to Buy. Bruker earned $0.45 in the second quarter, compared to $0.44 in the year-ago quarter. At the moment, the stock has a 52-week-high of $83.69 and a 52-week-low of $55.80. Bruker closed at $59.71 at the end of the last trading period.

For Vipshop Holdings Ltd (NYSE:VIPS), Citigroup upgraded the previous rating of Sell to Neutral. For the second quarter, Vipshop Holdings had an EPS of $0.37, compared to year-ago quarter EPS of $0.32. The stock has a 52-week-high of $11.58 and a 52-week-low of $5.75. At the end of the last trading period, Vipshop Holdings closed at $9.99.

See all analyst ratings upgrades.

Downgrades

CFRA downgraded the previous rating for Netflix Inc (NASDAQ:NFLX) from Hold to Sell. For the second quarter, Netflix had an EPS of $3.20, compared to year-ago quarter EPS of $2.97. At the moment, the stock has a 52-week-high of $609.99 and a 52-week-low of $162.71. Netflix closed at $241.16 at the end of the last trading period.

For Clarus Therapeutics Holdings Inc (NASDAQ:CRXT), Maxim Group downgraded the previous rating of Buy to Hold. Clarus Therapeutics Hldgs earned $0.21 in the second quarter, compared to $0.00 in the year-ago quarter. At the moment, the stock has a 52-week-high of $3.94 and a 52-week-low of $0.20. Clarus Therapeutics Hldgs closed at $0.21 at the end of the last trading period.

Evercore ISI Group downgraded the previous rating for United Parcel Service Inc (NYSE:UPS) from Outperform to In-Line. United Parcel Service earned $3.29 in the second quarter, compared to $3.06 in the year-ago quarter. At the moment, the stock has a 52-week-high of $233.72 and a 52-week-low of $165.34. United Parcel Service closed at $208.43 at the end of the last trading period.

According to Evercore ISI Group, the prior rating for Canadian National Railway Co (NYSE:CNI) was changed from Outperform to In-Line. In the second quarter, Canadian National Railway showed an EPS of $1.51, compared to $1.21 from the year-ago quarter. The current stock performance of Canadian National Railway shows a 52-week-high of $137.19 and a 52-week-low of $106.61. Moreover, at the end of the last trading period, the closing price was at $126.72.

For Saia Inc (NASDAQ:SAIA), Evercore ISI Group downgraded the previous rating of Outperform to In-Line. Saia earned $4.10 in the second quarter, compared to $2.34 in the year-ago quarter. The current stock performance of Saia shows a 52-week-high of $342.99 and a 52-week-low of $168.03. Moreover, at the end of the last trading period, the closing price was at $229.46.

According to Needham, the prior rating for NeoGenomics Inc (NASDAQ:NEO) was changed from Buy to Hold. In the second quarter, NeoGenomics showed an EPS of $0.16, compared to $0.01 from the year-ago quarter. At the moment, the stock has a 52-week-high of $35.34 and a 52-week-low of $6.85. NeoGenomics closed at $11.14 at the end of the last trading period.

Cowen & Co. downgraded the previous rating for VF Corp (NYSE:VFC) from Outperform to Market Perform. VF earned $0.09 in the first quarter, compared to $0.27 in the year-ago quarter. The stock has a 52-week-high of $76.61 and a 52-week-low of $43.08. At the end of the last trading period, VF closed at $45.55.

According to Goldman Sachs, the prior rating for Gritstone Bio Inc (NASDAQ:GRTS) was changed from Neutral to Sell. In the second quarter, Gritstone Bio showed an EPS of $0.34, compared to $0.33 from the year-ago quarter. The stock has a 52-week-high of $13.01 and a 52-week-low of $1.71. At the end of the last trading period, Gritstone Bio closed at $4.19.

For Intra-Cellular Therapies Inc (NASDAQ:ITCI), Goldman Sachs downgraded the previous rating of Buy to Neutral. For the second quarter, Intra-Cellular Therapies had an EPS of $0.92, compared to year-ago quarter EPS of $0.85. The stock has a 52-week-high of $66.00 and a 52-week-low of $38.51. At the end of the last trading period, Intra-Cellular Therapies closed at $51.42.

For Coupa Software Inc (NASDAQ:COUP), RBC Capital downgraded the previous rating of Sector Perform to Underperform. Coupa Software earned $0.08 in the first quarter, compared to $0.07 in the year-ago quarter. The current stock performance of Coupa Software shows a 52-week-high of $166.21 and a 52-week-low of $50.54. Moreover, at the end of the last trading period, the closing price was at $67.77.

For DocuSign Inc (NASDAQ:DOCU), RBC Capital downgraded the previous rating of Outperform to Sector Perform. For the first quarter, DocuSign had an EPS of $0.38, compared to year-ago quarter EPS of $0.44. The current stock performance of DocuSign shows a 52-week-high of $157.37 and a 52-week-low of $55.86. Moreover, at the end of the last trading period, the closing price was at $65.92.

See all analyst ratings downgrades.

Initiations

EF Hutton initiated coverage on Blue Star Foods Corp (NASDAQ:BSFC) with a Buy rating. The price target for Blue Star Foods is set to $2.50. The stock has a 52-week-high of $6.80 and a 52-week-low of $1.04. At the end of the last trading period, Blue Star Foods closed at $1.22.

Raymond James initiated coverage on Waldencast PLC (NASDAQ:WALD) with an Outperform rating. The price target for Waldencast is set to $11.00. The stock has a 52-week-high of $10.89 and a 52-week-low of $6.56. At the end of the last trading period, Waldencast closed at $9.10.

Piper Sandler initiated coverage on CinCor Pharma Inc (NASDAQ:CINC) with an Overweight rating. The price target for CinCor Pharma is set to $73.00. In the second quarter, CinCor Pharma showed an EPS of $0.56, compared to $4.81 from the year-ago quarter. The current stock performance of CinCor Pharma shows a 52-week-high of $43.15 and a 52-week-low of $13.00. Moreover, at the end of the last trading period, the closing price was at $33.16.

See all analyst ratings initiations.

BRKRBruker Corp

$60.450.67%

Overview

BSFCBLUE STAR FOODS CORP by BLUE STAR FOODS CORP.

$0.00040-99.9%

CNICanadian National Railway Co

$129.760.68%

DOCUDocusign Inc

$53.300.74%

ELVElevance Health Inc

$382.491.09%